Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial [0.03%]
阿司匹林在心血管疾病及糖尿病中的疗效对比：ADAPTABLE试验亚组分析
Dennis I Narcisse,Hwasoon Kim,Lisa M Wruck et al.
Dennis I Narcisse et al.
Objective: Patients with diabetes mellitus (DM) and concomitant atherosclerotic cardiovascular disease (ASCVD) must be on the most effective dose of aspirin to mitigate risk of future adverse cardiovascular events. ...
Randomized Controlled Trial
Diabetes care. 2024 Jan 1;47(1):81-88. DOI:10.2337/dc23-0749 2024
Family Typology for Adults With Type 2 Diabetes: Longitudinal Stability and Validity for Diabetes Management and Well-being [0.03%]
成人2型糖尿病家庭分型：纵向稳定性及对糖尿病管理和幸福感的有效性研究
Lindsay S Mayberry,Shilin Zhao,McKenzie K Roddy et al.
Lindsay S Mayberry et al.
Objective: We validated longitudinally a typology of diabetes-specific family functioning (named Collaborative and Helpful, Satisfied with Low Involvement, Want More Involvement, and Critically Involved) in adults with ty...
Ingrid Libman,Polly J Bingley,Dorothy Becker et al.
Ingrid Libman et al.
Objective: Innate immune responses may be involved in the earliest phases of type 1 diabetes (T1D). Research design and methods: To tes...
Empagliflozin Normalizes Fasting Hyperglycemia and Improves Postprandial Glucose Tolerance in Totally Pancreatectomized Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study [0.03%]
恩格列净可纠正全胰切除患者的空腹高血糖并改善餐后血糖耐量：随机双盲安慰剂对照交叉试验
Mille Baekdal,Sophie W Nielsen,Carsten P Hansen et al.
Mille Baekdal et al.
Objective: Insulin remains the only glucose-lowering treatment modality recommended for totally pancreatectomized patients. We investigated the effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on fast...
Randomized Controlled Trial
Diabetes care. 2024 Jan 1;47(1):71-80. DOI:10.2337/dc23-0645 2024
Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes [0.03%]
儿童1型糖尿病的性别差异：诊断年龄、HLA基因型和自身抗体谱型分布不同
Jasaman Tojjar,Matti Cervin,Emma Hedlund et al.
Jasaman Tojjar et al.
Objective: To examine sex differences in children with newly diagnosed type 1 diabetes (T1D) with respect to age at diagnosis, presence of autoantibodies (GAD antibody [GADA], insulinoma-associated protein 2 [IA-2A], insu...
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes [0.03%]
根据糖尿病的衰弱程度比较SGLT-2抑制剂、GLP-1受体激动剂和DPP-4抑制剂的心血管疗效和安全性
Alexander Kutz,Dae Hyun Kim,Deborah J Wexler et al.
Alexander Kutz et al.
Objective: To evaluate the comparative cardiovascular effectiveness and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is), glucagon-like peptide 1 receptor agonists (GLP-1RAs), and dipeptidyl peptidase 4 inhi...
Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes [0.03%]
人口筛查高危婴幼儿的家长焦虑及其风险感知调查
Holly K O&#x;Donnell,Cristy Geno Rasmussen,Fran Dong et al.
Holly K O&#x;Donnell et al.
Objective: To assess anxiety and risk perception among parents whose children screened positive for islet autoantibodies, indicating elevated risk for type 1 diabetes (T1D). ...
Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1-4 Trials [0.03%]
利拉塞肽实现正常血糖的效果：来自SURPASS 1-4试验的分析
Julio Rosenstock,Luis Vázquez,Stefano Del Prato et al.
Julio Rosenstock et al.
Objective: Tirzepatide is a novel single-molecule glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, which demonstrated unprecedented improvements in glycemic control and body weight re...
Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials [0.03%]
基于血糖定义的糖尿病前期分型的常规生活方式干预对2型糖尿病发病的影响：随机对照试验的个体参与者数据Meta分析研究
Thirunavukkarasu Sathish,Kamlesh Khunti,K M Venkat Narayan et al.
Thirunavukkarasu Sathish et al.
Objective: To examine whether the effect of conventional lifestyle interventions on type 2 diabetes incidence differs by glucose-defined prediabetes phenotype. ...
Meta-Analysis
Diabetes care. 2023 Nov 1;46(11):1903-1907. DOI:10.2337/dc23-0696 2023
Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes [0.03%]
丹麦1型和2型糖尿病患者远端对称多发性神经病变发病率下降，伴有1型糖尿病的不同模式迹象
Hatice Isik Mizrak,Tine Willum Hansen,Peter Rossing et al.
Hatice Isik Mizrak et al.
Objective: It is not known if incidence rates for diabetic distal symmetric polyneuropathy (DSPN) are decreasing, as they are for other diabetic complications. Here, we investigated incidence rates of DSPN in type 1 and t...